Sotera Health (NASDAQ:SHC) Sees Unusually-High Trading Volume – What’s Next?

Sotera Health Company (NASDAQ:SHC) shares saw strong trading volume on Thursday . 3,362,101 shares changed hands during mid-day trading, an increase of 92% from the previous session’s volume of 1,754,847 shares.The stock last traded at $15.21 and had previously closed at $15.76.

Analyst Ratings Changes

A number of research analysts recently issued reports on SHC shares. Wells Fargo & Company lowered Sotera Health to an “overweight” rating in a report on Thursday, January 8th. BMO Capital Markets assumed coverage on Sotera Health in a research note on Thursday, November 13th. They issued an “outperform” rating and a $19.00 price objective for the company. Weiss Ratings reissued a “hold (c-)” rating on shares of Sotera Health in a research report on Monday, December 29th. Royal Bank Of Canada started coverage on shares of Sotera Health in a research note on Thursday, January 8th. They set an “outperform” rating and a $24.00 target price on the stock. Finally, Zacks Research cut shares of Sotera Health from a “strong-buy” rating to a “hold” rating in a report on Friday, January 30th. Eight equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $20.43.

Sotera Health Stock Performance

The firm’s 50-day moving average is $17.73 and its 200 day moving average is $16.83. The stock has a market cap of $4.17 billion, a PE ratio of 54.30 and a beta of 1.84. The company has a debt-to-equity ratio of 3.66, a quick ratio of 2.24 and a current ratio of 2.46.

Sotera Health (NASDAQ:SHC) last issued its quarterly earnings results on Tuesday, February 24th. The company reported $0.26 earnings per share for the quarter, topping analysts’ consensus estimates of $0.24 by $0.02. The firm had revenue of $303.44 million during the quarter, compared to analysts’ expectations of $300.68 million. Sotera Health had a net margin of 6.70% and a return on equity of 42.38%. Sotera Health’s quarterly revenue was up 4.6% compared to the same quarter last year. During the same quarter in the prior year, the business earned $0.21 EPS. Sotera Health has set its FY 2026 guidance at 0.930-1.01 EPS. As a group, research analysts anticipate that Sotera Health Company will post 0.61 EPS for the current year.

Insider Buying and Selling at Sotera Health

In related news, CEO Michael B. Jr. Petras sold 434,104 shares of the firm’s stock in a transaction dated Monday, December 8th. The stock was sold at an average price of $16.45, for a total transaction of $7,141,010.80. The transaction was disclosed in a document filed with the SEC, which is available at this link. Insiders have sold a total of 1,184,104 shares of company stock worth $19,478,511 in the last three months. 47.55% of the stock is currently owned by corporate insiders.

Institutional Trading of Sotera Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Sculptor Capital LP lifted its position in Sotera Health by 57.4% during the 4th quarter. Sculptor Capital LP now owns 21,000,000 shares of the company’s stock worth $370,440,000 after acquiring an additional 7,658,200 shares during the period. Vanguard Group Inc. increased its holdings in shares of Sotera Health by 16.7% in the fourth quarter. Vanguard Group Inc. now owns 19,228,375 shares of the company’s stock valued at $339,189,000 after purchasing an additional 2,756,583 shares during the period. Sachem Head Capital Management LP raised its stake in shares of Sotera Health by 47.2% during the fourth quarter. Sachem Head Capital Management LP now owns 11,645,000 shares of the company’s stock worth $205,418,000 after purchasing an additional 3,735,000 shares during the last quarter. Janus Henderson Group PLC raised its stake in shares of Sotera Health by 4.8% during the fourth quarter. Janus Henderson Group PLC now owns 6,772,059 shares of the company’s stock worth $119,460,000 after purchasing an additional 312,191 shares during the last quarter. Finally, State Street Corp lifted its holdings in shares of Sotera Health by 21.0% during the fourth quarter. State Street Corp now owns 5,965,326 shares of the company’s stock worth $105,228,000 after purchasing an additional 1,035,457 shares during the period. 91.03% of the stock is owned by hedge funds and other institutional investors.

About Sotera Health

Sotera Health Inc (NASDAQ: SHC) is a global provider of sterilization and laboratory testing services that support the medical device, pharmaceutical, life sciences and consumer product industries. Headquartered in Jacksonville, Florida, the company offers a suite of services designed to ensure products meet rigorous safety and regulatory requirements before reaching market.

Sotera Health operates through three primary service platforms. Its Sterigenics division delivers contract sterilization solutions, including ethylene oxide (EtO), gamma irradiation, electron beam and X-ray technologies.